WuXi AppTec New Drug Development Co., Ltd. was founded in December 2000 and is a leading pharmaceutical, biotechnology and medical device R&D outsourcing service company, with operating entities in both China and the United States. As a research-first, customer-centric company, WuXi AppTec provides a full range of laboratory R&D and research-production services to global pharmaceutical companies, biotechnology companies and medical device companies, covering the entire process from drug discovery to market launch. WuXi AppTec's services are designed to help global customers shorten drug and medical device R&D cycles and reduce R&D costs through cost-effective, high-efficiency outsourcing services.
Over more than a decade, WuXi AppTec has successfully built a comprehensive integrated R&D service technology platform. At its inception, WuXi AppTec achieved all-round development by virtue of its strong strength in discovery chemical synthesis. In recent years, we have added a series of integrated services, including analytical services, bioanalytical services, process research, process R&D services, API production services, drug metabolism and pharmacokinetics services, R&D biology, pharmacology, formulation, toxicology, genomics services, biologics production services, production and sales services of antibodies and biodiagnostic reagents, and clinical R&D and product registration services.
From its founding in December 2000 to the present, WuXi AppTec's employee count has grown from 4 to over **********, and its laboratories have grown from a single room at the beginning to nearly 300,000 square meters of R&D bases and production plants. At the same time, WuXi AppTec continues to strengthen its service capabilities and broaden its service areas to better serve the company's continuously growing global business needs. As a leading pharmaceutical R&D outsourcing service company, WuXi AppTec will continue to be committed to providing high-quality pharmaceutical R&D services to global customers in both China and the United States, helping to develop more new drugs and products that benefit patients.
WuXi AppTec's headquarters contact address is as follows:
Shanghai WuXi AppTec
Address: No. 288 Fut Middle Road, Waigaoqiao Free Trade Zone, Shanghai (Postal Code: **********)
Email: ********@****.***
Nanjing Meisinuo Pharmaceutical Technology Co., Ltd., founded in 2008, was formally merged into WuXi AppTec in 2014. Meisinuo specializes in research in drug metabolism, pharmacokinetics, organic and analytical chemistry, and quantitative bioanalysis for clinical and preclinical projects, providing scientific research, development and consulting services to the pharmaceutical, biotechnology, agrochemical and other chemical industries.
Nanjing Meisinuo leverages the strong financial and technical strength of the headquarters. With a responsible attitude toward customers, shareholders and employees, it takes "honest and dedicated, sharing hardships and prosperity" as its company creed, and takes customer first, owner spirit, self-respect, self-discipline and self-improvement, and pursuit of excellence as its core values, aiming to provide high-end preclinical drug safety evaluation research services for new drug development at home and abroad.
We look forward to relying on your talents to enrich our team. We welcome talents from all over to join us and develop and progress together with WuXi AppTec. WuXi AppTec will provide employees with good career prospects and numerous training opportunities as well as competitive salary and benefits.
What does Nanjing WuXi AppTec New Drug Development Co., Ltd. require? Who is Nanjing WuXi AppTec New Drug Development Co., Ltd. hiring? recruitment: 其他(研发和技术类)占比最多占46.7%,其次是科研类占46.7%. What education can get in at ? 本科占比最多占53.3%,其次是大专占33.3%. High education required at ? 硕士占6.7%,博士占6.7%. Work experience required at ? 不限占比最多占93.3%,其次是1-3年占6.7%. Where are the job locations at ? 南京占比最多占73.3%,其次是苏州占26.7%. Based on job postings from the past year, for reference only.
Congratulations, submitted successfully!
Your edit is under review. You will be notified by email within 1 business day.
Submission failed.
Help others learn about this company, add my impression of this company»
Log in with the following accounts to save your follows